Home › Asset managers › Compare 2024-2025 › BlackRock vs ProShares
BlackRock 2024-2025 · ProShares 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 8,258 | 7,560 | 520 | 178 | 93.6% | 92.8% |
| Board proposals | 7,109 | 6,611 | 367 | 131 | 94.7% | 94.1% |
| E&S shareholder proposals | 234 | 184 | 23 | 27 | 88.9% | 87.4% |
| Other items | 915 | 765 | 130 | 20 | 85.5% | 84.3% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
498 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | BlackRock | ProShares |
|---|---|---|---|---|---|---|
| 374WATER INC. | June 11, 2025 | Approval of certain amendments to the Company's 2021 Equity Incentive Plan to (i) increase the amount of authorized common stock of the Company issuable under the 2021 Equity Incentive Plan by 12,150,000 shares and (ii) increase the individual non- employee director compensation limit to $300,000 in any calendar year. Compensation |
Board | For | FOR 4 funds |
AGAINST 8 funds |
| 3D SYSTEMS CORP. | August 30, 2024 | The approval of the amendment and restatement of the 2015 Incentive Plan that, among other things, increases the number of shares reserved for issuance thereunder by 4,000,000 shares. Compensation |
Board | For | FOR 12 funds |
AGAINST 11 funds |
| 8X8 INC. | August 15, 2024 | To approve an amendment to the 2022 Equity Incentive Plan to increase the number of shares of common stock available for issuance thereunder by 14,000,000 shares. Compensation |
Board | For | FOR 13 funds |
AGAINST 7 funds |
| ADAPTIVE BIOTECHNOLOGIES CORP. | June 10, 2025 | To elect one Class III director nominee to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2028 annual meeting of shareholders; Chad Robins Director Elections |
Board | For | FOR 10 funds |
WITHHOLD 9 funds |
| ADT INC. | May 21, 2025 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 30 funds |
AGAINST 1 fund |
| ADVANCED FLOWER CAPITAL INC. | May 19, 2025 | Election of Director: Robert Levy Director Elections |
Board | For | FOR 8 funds |
AGAINST 8 funds |
| ADVERUM BIOTECHNOLOGIES INC. | June 17, 2025 | To approve the amendment and restatement of the Adverum Biotechnologies, Inc. 2024 Equity Incentive Award Plan. Compensation |
Board | For | FOR 5 funds |
AGAINST 4 funds |
| AERSALE CORP. | June 5, 2025 | To approve the Second Amendment to the AerSale Corporation 2020 Equity Incentive Plan. Compensation |
Board | For | FOR 8 funds |
AGAINST 8 funds |
| AEVA TECHNOLOGIES INC. | June 20, 2025 | Approval, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 8 funds |
| AGENUS INC. | June 17, 2025 | To approve an amendment to our Amended and Restated 2019 Equity Incentive Plan ("2019 EIP") to increase the number of shares of common stock authorized for issuance thereunder from 5,050,000 shares to 12,050,000 shares. Compensation |
Board | For | FOR 6 funds |
AGAINST 8 funds |
| AGIOS PHARMACEUTICALS INC. | June 18, 2025 | To approve an amendment to the Agios Pharmaceuticals, Inc. 2023 Stock Incentive Plan, to increase the number of shares of common stock available thereunder by 2,500,000 shares. Compensation |
Board | For | FOR 16 funds |
AGAINST 11 funds |
| AIR LEASE | May 2, 2025 | Advisory vote to approve named executive officer compensation Say-on-Pay |
Board | Not determined | FOR 33 funds |
AGAINST 3 funds |
| AIR TRANSPORT SERVICES GROUP INC. | February 10, 2025 | To approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to the Company's named executive officers in connection with the consummation of the merger (the "Advisory Compensation Proposal"). Say-on-Pay |
Board | For | FOR 22 funds |
AGAINST 9 funds |
| AIRBNB INC | June 4, 2025 | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 67 funds |
AGAINST 26 funds |
| AKAMAI TECHNOLOGIES INC. | May 14, 2025 | To approve an amendment to our Second Amended and Restated 2013 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 8,000,000 shares. Compensation |
Board | For | FOR 49 funds |
AGAINST 20 funds |
| ALARM.COM HOLDINGS INC. | June 4, 2025 | To approve the Alarm.com Holdings, Inc. 2025 Equity Incentive Plan. Compensation |
Board | For | FOR 24 funds |
AGAINST 13 funds |
| ALBEMARLE CORP. | May 6, 2025 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 50 funds |
AGAINST 18 funds |
| ALICO INC. | February 28, 2025 | Approval of the amendment and restatement of the Alico, Inc. Stock Incentive Plan of 2015. Compensation |
Board | For | FOR 6 funds |
AGAINST 8 funds |
| ALIMERA SCIENCES INC. | September 4, 2024 | To approve, by non-binding, advisory vote, the compensation that will or may be paid or become payable to our named executive officers that is based on or otherwise relates to the Merger. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 3 funds |
| ALLEGIANT TRAVEL CO. | June 26, 2025 | Approval of an amendment to the Allegiant Travel Company 2022 Long-Term Incentive Plan. Compensation |
Board | For | FOR 14 funds |
AGAINST 11 funds |
| ALLY FINANCIAL INC. | May 6, 2025 | Advisory vote on executive compensation. Say-on-Pay |
Board | For | FOR 50 funds |
AGAINST 7 funds |
| ALPHATEC HOLDINGS INC. | June 11, 2025 | Approval of an amendment to our 2016 Equity Incentive Plan. Compensation |
Board | For | FOR 12 funds |
AGAINST 8 funds |
| ALTI GLOBAL INC. | June 16, 2025 | To approve an amendment to the Company's 2023 Stock Incentive Plan to increase the number of shares of Class A Common Stock available for issuance under the Company's 2023 Stock Incentive Plan and the number of shares that may be issued pursuant to incentive stock options by an additional 9,010,000 shares. Compensation |
Board | For | FOR 6 funds |
AGAINST 8 funds |
| AMAZON.COM | May 21, 2025 | ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION Say-on-Pay |
Board | For | FOR 107 funds |
AGAINST 37 funds |
| AMC NETWORKS INC | June 5, 2025 | Advisory vote on Named Executive Officer compensation Say-on-Pay |
Board | For | FOR 26 funds |
AGAINST 8 funds |
| AMERICAN INTERNATIONAL GROUP INC. | May 14, 2025 | Advisory Vote to Approve Named Executive Officer Compensation. Say-on-Pay |
Board | For | FOR 58 funds |
AGAINST 16 funds |
| ANAPTYSBIO INC. | June 17, 2025 | To approve an amendment to our 2017 Equity Incentive Plan. Compensation |
Board | For | FOR 15 funds |
AGAINST 11 funds |
| ANAVEX LIFE SCIENCES CORP. | June 10, 2025 | To approve an amendment to the Company's 2022 Omnibus Incentive Plan. Compensation |
Board | For | FOR 11 funds |
AGAINST 11 funds |
| ANTERIX INC. | August 6, 2024 | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 20 funds |
AGAINST 7 funds |
| ANTERO RESOURCES CORP. | June 4, 2025 | To approve, on an advisory basis, the compensation of Antero Resources Corporation's named executive officers. Say-on-Pay |
Board | For | FOR 44 funds |
AGAINST 7 funds |
| ANYWHERE REAL ESTATE INC. | May 7, 2025 | Approval of the Third Amended and Restated 2018 Long-Term Incentive Plan. Compensation |
Board | For | FOR 11 funds |
AGAINST 8 funds |
| APPLIED DIGITAL CORP. | November 20, 2024 | Approve the Company's 2024 Equity Compensation Plan and the reservation of 10,000,000 shares of common stock for issuance thereunder. Compensation |
Board | For | FOR 9 funds |
AGAINST 8 funds |
| APPLIED THERAPEUTICS INC. | June 9, 2025 | Election of Director: Teena Lerner Director Elections |
Board | For | FOR 10 funds |
AGAINST 9 funds |
| AQUESTIVE THERAPEUTICS INC. | June 11, 2025 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 14 funds |
AGAINST 9 funds |
| ARBOR REALTY TRUST INC. | May 21, 2025 | Advisory vote to approve the compensation of Arbor Realty Trust, Inc.'s named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 24 funds |
AGAINST 12 funds |
| ARCUTIS BIOTHERAPEUTICS INC. | June 12, 2025 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 26 funds |
AGAINST 11 funds |
| ARDELYX INC. | June 18, 2025 | To approve the Amendment to the Amended and Restated 2014 Equity Incentive Award Plan. Compensation |
Board | For | FOR 11 funds |
AGAINST 11 funds |
| ARLO TECHNOLOGIES INC. | June 20, 2025 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 28 funds |
AGAINST 13 funds |
| ARRAY TECHNOLOGIES INC. | May 20, 2025 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 22 funds |
AGAINST 9 funds |
| ASPEN AEROGELS INC. | April 30, 2025 | Approval of the Aspen Aerogels Amended and Restated 2023 Equity Incentive Plan. Compensation |
Board | For | FOR 11 funds |
AGAINST 8 funds |
| AST SPACEMOBILE INC. | June 6, 2025 | To approve a non-binding advisory vote on the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 24 funds |
AGAINST 8 funds |
| ASTRIA THERAPEUTICS INC. | June 11, 2025 | The approval of the first amendment to our Second Amended and Restated 2015 Stock Incentive Plan, to increase the number of shares of our common stock available for grant under the plan by 5,500,000 shares. Compensation |
Board | For | FOR 13 funds |
AGAINST 9 funds |
| ASTRIA THERAPEUTICS INC. | June 11, 2025 | The approval, by non-binding advisory vote, of our executive compensation. Say-on-Pay |
Board | For | FOR 21 funds |
AGAINST 9 funds |
| ASURE SOFTWARE INC. | June 2, 2025 | To approve an amendment to the Asure Software, Inc. 2018 Incentive Award Plan to increase the number of shares of our common stock authorized for issuance by 2,250,000 shares. Compensation |
Board | For | FOR 7 funds |
AGAINST 8 funds |
| AVANOS MEDICAL INC. | April 24, 2025 | Approval of an amendment to the Company's 2021 Long Term Incentive Plan to increase the number of shares reserved for issuance thereunder by 2,250,000 shares. Compensation |
Board | For | FOR 13 funds |
AGAINST 11 funds |
| AVIAT NETWORKS INC. | November 6, 2024 | Approval of the Second Amended and Restated 2018 Incentive Plan of the Company. Compensation |
Board | For | FOR 9 funds |
AGAINST 8 funds |
| AVITA MEDICAL INC. | June 4, 2025 | To approve (a) the 2020 Omnibus Incentive Plan Amended and Restated (the "Plan"), the terms of which are summarized in this Proxy Statement; and (b) for purposes of ASX Listing Rule 7.2 Exception 13(b), which provides an exception to ASX Listing Rule 7.1, the issuance of the Company's equity securities under the Plan, in accordance with its terms and conditions, for a period of up to three years from the date of stockholder approval. Compensation |
Board | For | FOR 8 funds |
AGAINST 8 funds |
| AXOS FINANCIAL INC. | November 14, 2024 | To approve in a non-binding and advisory vote, the compensation of the Company's Named Executive Officers as disclosed in this Proxy Statement. Say-on-Pay |
Board | For | FOR 30 funds |
AGAINST 15 funds |
| AXSOME THERAPEUTICS INC. | June 6, 2025 | Election of Director: Roger Jeffs, Ph.D. Director Elections |
Board | For | FOR 18 funds |
WITHHOLD 11 funds |
| AXSOME THERAPEUTICS INC. | June 6, 2025 | To approve the Company's 2025 Long-Term Incentive Plan. Compensation |
Board | For | FOR 18 funds |
AGAINST 11 funds |
| BANDWIDTH INC. | May 29, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 20 funds |
AGAINST 8 funds |
| BANK OF AMERICA CORP. | April 22, 2025 | Amending and restating the Bank of America Corporation Equity Plan Compensation |
Board | For | FOR 60 funds |
AGAINST 19 funds |
| BANK OF AMERICA CORP. | April 22, 2025 | Approving our executive compensation (an advisory, non-binding "Say on Pay" resolution) Say-on-Pay |
Board | For | FOR 77 funds |
AGAINST 19 funds |
| BEIGENE LTD | May 21, 2025 | THAT, on a non-binding, advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, be and is hereby approved. Say-on-Pay |
Board | For | FOR 12 funds |
AGAINST 4 funds |
| BERRY GLOB | February 25, 2025 | Proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to Berry's named executive officers that is based on or otherwise relates to the transactions contemplated by the Merger Agreement, which proposal is referred to as the "Berry Advisory Compensation Proposal." Say-on-Pay |
Board | Not determined | FOR 35 funds |
AGAINST 8 funds |
| BEYOND INC. | May 15, 2025 | The approval of an amendment and restatement of the Company's Amended and Restated 2005 Equity Incentive Plan (the "2005 Plan"). Compensation |
Board | For | FOR 6 funds |
AGAINST 10 funds |
| BGC GROUP INC. | September 16, 2024 | Approval, on an advisory basis, of executive compensation. Say-on-Pay |
Board | For | FOR 25 funds |
AGAINST 12 funds |
| BIOCRYST PHARMACEUTICALS INC. | June 12, 2025 | To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan. Compensation |
Board | For | FOR 19 funds |
AGAINST 11 funds |
| BLACKROCK FINANCE INC. | May 15, 2025 | Approval, in a non-binding advisory vote, of the compensation for named executive officers. Say-on-Pay |
Board | For | FOR 53 funds |
AGAINST 7 funds |
| BLINK CHARGING CO. | July 16, 2024 | Approve, on a non-binding advisory basis, the compensation paid to our executive officers. Say-on-Pay |
Board | For | FOR 14 funds |
AGAINST 7 funds |
| BOX INC. | July 2, 2024 | To approve our Amended and Restated 2015 Equity Incentive Plan. Compensation |
Board | For | FOR 25 funds |
AGAINST 16 funds |
| BOX INC. | June 27, 2025 | To approve an amendment to our Amended and Restated 2015 Equity Incentive Plan to increase the number of shares reserved for issuance by 5,000,000 shares. Compensation |
Board | For | FOR 27 funds |
AGAINST 15 funds |
| BRANDYWINE REALTY TRUST | May 21, 2025 | Adoption of an amendment to the 2023 Long-Term Incentive Plan. Compensation |
Board | For | FOR 20 funds |
AGAINST 11 funds |
| BRIDGEBIO PHARMA INC. | June 20, 2025 | To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 5,000,000 shares. Compensation |
Board | For | FOR 21 funds |
AGAINST 11 funds |
| BROOKLINE BANCORP INC. | May 21, 2025 | A proposal to approve, on a non-binding advisory basis, the compensation that may become payable to the named executive officers of Brookline in connection with the Mergers (the "Brookline Merger-Related Compensation Proposal"). Say-on-Pay |
Board | For | FOR 23 funds |
AGAINST 11 funds |
| BRUKER CORP. | May 29, 2025 | Approval of the adoption of the Bruker Corporation 2026 Incentive Compensation Plan. Compensation |
Board | For | FOR 31 funds |
AGAINST 10 funds |
| BUMBLE INC. | June 5, 2025 | Approval, on a non-binding advisory basis, of the compensation of the named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 24 funds |
AGAINST 8 funds |
| BURFORD CAPITAL LIMITED | May 14, 2025 | To re-elect John Sievwright as director. Director Elections |
Board | For | AGAINST 6 funds |
FOR 4 funds |
| C.H. ROBINSON WORLDWIDE INC. | May 8, 2025 | To approve the Amended and Restated 2022 Equity Incentive Plan. Compensation |
Board | For | FOR 44 funds |
AGAINST 19 funds |
| CABALETTA BIO INC. | June 9, 2025 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 12 funds |
AGAINST 8 funds |
| CACTUS INC. | May 13, 2025 | To approve the amendment of the Company's Long-Term Incentive Plan, as amended and restated effective May 16, 2023, to increase the number of shares of the Company's Class A common stock reserved for issuance under such plan from 5,500,000 to 8,500,000. Compensation |
Board | For | FOR 17 funds |
AGAINST 12 funds |
| CADIZ INC. | June 12, 2025 | Advisory vote on executive compensation as disclosed in the proxy materials. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 8 funds |
| CALIFORNIA WATER SERVICE GROUP | May 28, 2025 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 32 funds |
AGAINST 14 funds |
| CALIX INC. | May 8, 2025 | To approve 1,250,000 shares of common stock reserved for issuance for the matching component of the Calix, Inc. Stock Purchase and Matching Plan, which constitutes an amendment and restatement of the Third Amended and Restated 2017 Nonqualified Employee Stock Purchase Plan. Compensation |
Board | For | FOR 23 funds |
AGAINST 13 funds |
| CALIX INC. | May 8, 2025 | To approve the Calix, Inc. Fourth Amended and Restated 2019 Equity Incentive Award Plan. Compensation |
Board | For | FOR 23 funds |
AGAINST 13 funds |
| CALIX INC. | May 8, 2025 | To approve, on a non-binding, advisory basis, Calix's named executive officer compensation. Say-on-Pay |
Board | For | FOR 36 funds |
AGAINST 13 funds |
| CANOO INC. | December 6, 2024 | To approve an amendment to our 2020 Employee Stock Purchase Plan (the "ESPP") to increase the number of shares of our Common Stock available and reserved for issuance under the ESPP by an additional 1,000,000 shares of Common Stock. Compensation |
Board | For | AGAINST 4 funds |
FOR 4 funds |
| CARDLYTICS INC. | May 20, 2025 | Approval of the Cardlytics, Inc. 2025 Equity Incentive Plan. Compensation |
Board | For | FOR 6 funds |
AGAINST 8 funds |
| CAREDX INC. | June 12, 2025 | Approval of an amendment to 2024 Equity Incentive Plan. Compensation |
Board | For | FOR 17 funds |
AGAINST 10 funds |
| CARETRUST REIT INC. | April 29, 2025 | Approval, on an advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 40 funds |
AGAINST 14 funds |
| CENTESSA PHARMACEUTICALS PLC | June 20, 2025 | To generally and unconditionally authorise the directors of the Company or any duly authorised committee of the directors, in accordance with section 551 of the UK Companies Act 2006 (the "Companies Act"), to allot shares in the Company or grant rights to subscribe for or to convert any security into shares in the Company up to an aggregate nominal amount of pounds133,184. Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CENTURY ALUMINUM CO. | June 16, 2025 | Proposal to approve, on an advisory basis, the compensation of the named executive officers. Say-on-Pay |
Board | For | FOR 29 funds |
AGAINST 11 funds |
| CERVOMED INC. | June 23, 2025 | To approve the CervoMed Inc. 2025 Equity Incentive Plan. Compensation |
Board | For | FOR 4 funds |
AGAINST 4 funds |
| CEVA INC. | May 5, 2025 | To approve an amendment and restatement of the Company's 2011 Equity Incentive Plan. Compensation |
Board | For | FOR 14 funds |
AGAINST 14 funds |
| CHEGG INC. | June 4, 2025 | To approve the Chegg, Inc. Amendment to the 2023 Equity Incentive Plan. Compensation |
Board | For | FOR 6 funds |
AGAINST 8 funds |
| CHEMUNG FINANCIAL CORP. | June 3, 2025 | To approve the Chemung Financial Corporation 2025 Equity Incentive Plan. Compensation |
Board | For | FOR 6 funds |
AGAINST 8 funds |
| CHEWY | July 11, 2024 | To approve the Chewy, Inc. 2024 Omnibus Incentive Plan, including an increase in the number of shares reserved for issuance by 80,000,000 shares. Compensation |
Board | For | FOR 10 funds |
AGAINST 3 funds |
| CHUBB LIMITED | May 15, 2025 | Election of Evan G. Greenberg as Chairman of the Board of Directors Corporate Governance |
Board | For | FOR 34 funds |
AGAINST 16 funds |
| CIBUS INC | May 22, 2025 | Ratification of the appointment of BDO USA, P.C. as independent registered public accounting firm for the fiscal year ending December 31, 2025. Audit-related |
Board | For | FOR 4 funds |
AGAINST 4 funds |
| CIMPRESS PLC | November 20, 2024 | Amend Cimpress' 2020 Equity Incentive Plan to increase the number of ordinary shares issuable under the plan. Compensation |
Board | For | FOR 13 funds |
AGAINST 8 funds |
| CIMPRESS PLC | November 20, 2024 | Reappoint Dessislava Temperley to Cimpress' Board of Directors to serve for a term of three years. Director Elections |
Board | For | FOR 13 funds |
AGAINST 8 funds |
| CINTAS CORP. | October 29, 2024 | To approve the Cintas Corporation 2016 Amended and Restated Equity and Incentive Compensation Plan. Compensation |
Board | For | FOR 52 funds |
AGAINST 26 funds |
| CITI TRENDS INC. | June 5, 2025 | Vote to approve an Amendment to the 2021 Incentive Plan to increase the number of shares available by 500,000 for grant. Compensation |
Board | For | FOR 5 funds |
AGAINST 8 funds |
| CITIGROUP INC. | April 29, 2025 | Approval of additional shares for the Citigroup 2019 Stock Incentive Plan. Compensation |
Board | For | FOR 62 funds |
AGAINST 17 funds |
| CITIZENS & NORTHERN CORP. | April 24, 2025 | TO APPROVE, IN AN ADVISORY (NON-BINDING) VOTE, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT. Say-on-Pay |
Board | For | FOR 13 funds |
AGAINST 8 funds |
| CITIZENS FINANCIAL GROUP INC. | April 24, 2025 | Advisory Vote on Executive Compensation. Say-on-Pay |
Board | For | FOR 64 funds |
AGAINST 18 funds |
| CLARUS CORP. | May 29, 2025 | To consider and vote on a proposal to amend and restate the Company's 2015 Stock Incentive Plan to, among other things, extend the term of such plan by 10 years and reserve 7,500,000 shares of the Company's common stock for issuance under such plan. Compensation |
Board | For | FOR 6 funds |
AGAINST 8 funds |
| COASTAL FINANCIAL CORP. | May 28, 2025 | To approve the Second Amendment to the Coastal Financial Corporation 2018 Omnibus Incentive Plan (the "2018 Plan"), including an increase in the number of authorized shares under the 2018 Plan. Compensation |
Board | For | FOR 14 funds |
AGAINST 8 funds |
| CODEXIS INC. | June 10, 2025 | To approve an amendment to the Codexis, Inc. 2019 Incentive Award Plan to increase the number of shares available for issuance thereunder by 8,000,000 shares. Compensation |
Board | For | FOR 11 funds |
AGAINST 9 funds |
| CODEXIS INC. | June 10, 2025 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 18 funds |
AGAINST 9 funds |
Page 1 of 5 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.